PDL Professional Officers have observed an increase in formal requests for information regarding dispensed medicines from the Real Time Prescription Monitoring (RTPM) sections of health
The approval of the Pfizer Comirnaty Orange Cap (5-11 years) COVID-19 vaccine to be administered by pharmacists from 10 January 2022 offers opportunities and challenges for pharmacists. PDL encourages pharmacists to prepare for this
Pharmacist vaccination services are continuing to expand and PDL urges all pharmacists to consider the risk assessment and risk mitigation strategies needed to prevent errors
The PDL Professional Officers are aware of some issues relating to COVID-19 vaccinations administered by community pharmacists. To help minimise the risk of an incident
PDL has previously released Practice Alerts on Covid-19 vaccinations: Vaccinations 2021, on the 13th April discussing policy cover for vaccination services, including COVID-19 vaccines, and
PDL has observed a recent trend in pharmacists being duped into supplying medication, usually S8 or S4s on fraudulent prescriptions by con artists who are
PDL employs four pharmacist Professional Officers who are available 24/7 for PDL members. From the thousands of calls and emails received every year by the
Look before you leap’ is an old saying to remind someone to think about the consequences before acting-an adage that is applicable to the dispensing
It is not surprising that approximately 60% of reports to PDL involve dispensing errors. The PDL Professional Officers collate these reports and identify the sub-categories
PDL is aware that most community pharmacies and hospitals supply or encounter dosage administration aids (DAAs). Despite their purpose to enhance compliance and minimise dosage
Pharmaceutical Defence Limited (PDL) acknowledges the Traditional Owners of Country throughout Australia and their continuing connection to land, waters and community. We pay our respects to the people, the cultures and the Elders past and present.